Huazhebiotech (002007.SZ) subsidiary's new adjuvant influenza virus split vaccine approved to conduct clinical trials.

Wisdom Finance APP News, Hualan Biological (002007.SZ) announced that recently, the company's controlling subsidiary Hualan Biological Vaccine Co., Ltd. received the "Drug Clinical Trial Approval Notice" for the new adjuvant split influenza virus vaccine issued by the National Medical Products Administration.